Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: J Neural Transm (Vienna). 2021 Aug 13;128(11):1757–1765. doi: 10.1007/s00702-021-02396-y

Table 4.

Comparison of genotypes of significant result from the interaction analyses of previously implicated SNPs with a cumulative pre- and perinatal adversity score in relation to lifetime tic severity

SNP Genotype N Initial sample
Replication sample
Lifetime tic severity Mean (SD)a Cumulative pre- and perinatal adversity score Mean (SD) b β Standard error T Pc, d (Genotype) N β Standard error T Pc, d (Genotype)
rs6539267 TT 250 15.3 (8.20) 3.30 (3.32)   – 352
CT 224 15.7 (7.80) 3.77 (3.76) 0.039 0.21 − 1.87 0.06 344    0.74 0.61    1.20 0.23
CC   40 15.2 (9.62)   3.9 (3.75) 1.12 0.42    2.62 0.009   82 − 0.03 1.00 − 0.03 0.98

SNP single-nucleotide polymorphism

a

Lifetime worst-ever tic severity was assessed based on a modified version of the Yale Global Tic Severity Scale (Dietrich et al. 2015)

b

Cumulative pre- and perinatal adversity score (previously described in Abdulkadir et al. 2016) was constructed from addition of 38 possible adverse events as measured by the self-report or parent-on-child report version of the Modified Schedule for Risk and Protective Factors Early in Development questionnaire (Walkup and Leckman 1988)

c

Analyses were corrected for age, sex, and socioeconomic status

d

Major allele homozygous genotype was used as the reference genotype